Relative Bioavailability and Food Effect of Sonrotoclax Tablet for Oral Suspension in Healthy Adults

Phase 1, randomised, open-label trial of sonrotoclax in chronic lymphocytic leukemia (CLL), sponsored by BeOne Medicines. Primary endpoints: Area under the Plasma Concentration-Time Curve from Time 0 Extrapolated to Infinity at 20 days, Area under the Plasma Concentration-Time Curve from Time 0 to the Time of the Last Quantifiable Concentration at 20 days and 1 more. Started Jun 2026; status: completed.